FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for Protonix delayed-release (pantoprazole sodium) submitted by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• PROTONIX DELAYED-RELEASE (Pantoprazole sodium)

Snippet

SUPPL AP for PROTONIX DELAYED-RELEASE (PANTOPRAZOLE SODIUM)